ナイロンのストラップで,骨の内部を固定します.

Improving equity in prehabilitation before cancer surgery: consensus-based considerations for leaders and practitioners: a nominal group technique study.

Anaesthesia reports·2026

Vision-based manipulation of transparent plastic bags in industrial setups.

Frontiers in robotics and AI·2025

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.

European journal of cancer (Oxford, England : 1990)·2019

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.

British journal of cancer·2014

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

British journal of cancer·2014

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Plasma-induced chemical and structural activation of 2D nanomaterial coatings for antibacterial surfaces.

Nanoscale·2026

Current-Generation Crosslinked Polyethylenes for Total Hip Arthroplasty: Mechanistic Insights Into Oxidative Stability and Antioxidant Efficiency.

Journal of biomedical materials research. Part B, Applied biomaterials·2026

Lab-on-a-chip-compatible graphene oxide coatings via SAW atomization for supporting cell proliferation.

In vitro models·2026

The DD11 Material Components and Properties Impact and Relationship on Cutting Force in Progressive Stamping.

Materials (Basel, Switzerland)·2026

MXenes for Defense-Oriented Multifunctional Systems: From Synthesis and Property Regulation to Deployment Challenges.

Materials (Basel, Switzerland)·2026

Aging Trajectory Analysis of Asphalt: Differential Regulation of UV Aging Processes by Anti-Aging Agents with Varied Mechanisms.

Materials (Basel, Switzerland)·2026

関連する実験動画

ナイロンのストラップで,骨の内部を固定します.

関連する概念動画

Improving equity in prehabilitation before cancer surgery: consensus-based considerations for leaders and practitioners: a nominal group technique study.

Vision-based manipulation of transparent plastic bags in industrial setups.

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Plasma-induced chemical and structural activation of 2D nanomaterial coatings for antibacterial surfaces.

Current-Generation Crosslinked Polyethylenes for Total Hip Arthroplasty: Mechanistic Insights Into Oxidative Stability and Antioxidant Efficiency.

Lab-on-a-chip-compatible graphene oxide coatings via SAW atomization for supporting cell proliferation.

The DD11 Material Components and Properties Impact and Relationship on Cutting Force in Progressive Stamping.

MXenes for Defense-Oriented Multifunctional Systems: From Synthesis and Property Regulation to Deployment Challenges.

Aging Trajectory Analysis of Asphalt: Differential Regulation of UV Aging Processes by Anti-Aging Agents with Varied Mechanisms.

関連する実験動画

ナイロンのストラップで,骨の内部を固定します.

関連する概念動画

関連記事